Kidney Disease medication : The Benifits and Disadvantages of Ketosteril Tablets

 Ketosteril Tablets : Kidney Medicine

Ketosteril is a common medicine for various kidney problems. It helps relieve your symptoms while takes side effects at the same time. Read on and find the advantages and disadvantages on kidney disease patients. 

Benifits Of ketosteril Tablets 

Ketosteril Tablets Kidney Drugs

Ketosteril along with low protein intake can correct the carbohydrate metabolism disorder. It can reduce insulin resistance, increase energy and relieve hyperinsulinemia. 

Disadvantage Of Medicine 

Taking Ketosteril Tablets needs the patients to limit the animal protein intake strictly so it can reduce the sources of phosphorus from foods.

Also it can restrain the absorption of phosphorus by intestinal tract. Therefore, it is very likely to cause the calcium in blood to rise thus resulting in hypercalcemia which can cause multiple systems like digestive system, urinary system and renal tubule etc.

Everolimus 10 mg Tablets

Everolimus 10 mg Tablets Wholesale price Suppliers

Everolimus is a cancer medicine that interferes with the growth of cancer cells and slows their spread in the body.

The Everolimus Tablets is used to treat certain types of kidney cancer, breast cancer, or brain tumor. this medicine  is also used to treat certain types of advanced or progressive tumors of the stomach, intestines, or pancreas. it is usually given after other treatments have been tried without success.

Everolimus is also used to treat non-cancerous (benign) tumors of the kidney in people with a certain genetic condition called tuberous sclerosis complex.

Kidney Cancer Drugs

Sorafenib 200 mg - Sorafenat Natco Medicine - Soranib Cipla

Soranib 200mg Tablets Sorafenib 200 mg  is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma). Sorafenib 200 mg is a small molecular inhibitor of several Tyrosine protein kinases. (Protein kinases are overactive in many of the molecular pathways that cause cells to become cancerous). Sorafenib works along the multiple signaling pathways to block cell proliferation and tumor angiogenesis. It blocks the receptor tyrosine kinases VEGFR (Vascular Endothelial Growth Factor Receptor) and PDGFR (Platelet Derived Growth Factor Receptor) and the RAF serine/threonine kinases along the RAF/MEK/ERK pathway. Indications : RCC – Locally Advanced / Metastatic clear cell Renal cell carcinoma in patients, who have failed or unsuitable for cytokine therapy. HCC – Unresectable hepatocellular carcinoma. Dosage & Usage : 400mg – twice daily. High fat meal may decrease oral bioavailability of Sorafenib. Orally at least 1 hour before or 2 hours after a meal.

Soranib Drug Interactions : Potential pharmacokinetic interaction with doxorubicin and irinotecan (increased area under the serum concentration-time curve [AUC] of doxorubicin and of irinotecan and its active metabolite SN-38). Does not appear to affect the pharmacokinetics of gemcitabine or oxaliplatin.

Side Effects : • Hypophosphatemia, Diarrhea, Increased Lipase Concentrations, Rash/Desquamation, Fatigue, • Hand-foot Syndrome, • Increased Amylase Concentrations, • Alopecia, • Nausea, Lymphopenia, Pruritus, Neutropenia, Hypertension, Anorexia, Vomiting, Constipation,   Hemorrhage Dyspnea, Cough, Sensory Neuropathy, Dry Skin, Pain (Abdominal,   Joint, Headache, Mouth, Bone, And Tumor), Weight Loss, Erythema, Asthenia, And Leukopenia

Note: SORANIB Sorafenib 200 mg is to be used under proper medical guidance and advice.